Pacira BioSciences
PCRX
PCRX
270 hedge funds and large institutions have $1.44B invested in Pacira BioSciences in 2024 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 98 increasing their positions, 84 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
13% less capital invested
Capital invested by funds: $1.65B → $1.44B (-$217M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
70% less call options, than puts
Call options by funds: $4.61M | Put options by funds: $15.3M
Holders
270
Holding in Top 10
4
Calls
$4.61M
Puts
$15.3M
Top Buyers
| 1 | +$16.5M | |
| 2 | +$16.3M | |
| 3 | +$12.2M | |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$11.9M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$10.2M |
Top Sellers
| 1 | -$34.4M | |
| 2 | -$21.5M | |
| 3 | -$16.6M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$8.64M |
| 5 |
BlackRock
New York
|
-$6.42M |